Advangen Japan is a synergistic acquisition which builds on the foundation of CDY. Dr Takeo Matsumoto know's even at 5cents is greatly undervalued, they know the potential. Its a partnership made in heaven!!!! They know Midkine is the game changer thats why they wanted in, Midkine is already getting recognition. Give it some time you will be amazed.
We need to be realistic, don't be disappoint that the SP didn't hit everyones expectation. CDY's main priority is building a solid foundation with Advangen, then diagnostic & therapeutic, the byproduct will be the increase in the SP.
Rome wasn't built in a day, CDY is the same!!!! Patience, all we need is a little patience!!!
Cheers to all holders!!!
CDY Price at posting:
3.3¢ Sentiment: Buy Disclosure: Held
